holding glp 1 prior to surgery Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists How GLP‑1 Medications Support Sustainable
Description
In clinical trials, which compared people randomly assigned to the active drug or a placebo, participants receiving semaglutide or tirzepatide lost 15% to 20% of their body weight on average
October 17, 2023
243.Targher G, et al
These are not the same thing
2,3 Against this backdrop, oral GLP-1 receptor agonists are emerging as an increasingly important area of focus, as companies look to extend growth beyond injectables and broaden access to obesity care
